AVIRAGEN THERAPEUTICS - Profile, contacts and insights

AVIRAGEN THERAPEUTICS

Who is AVIRAGEN THERAPEUTICS?

Aviragen Therapeutics was acquired by Vaxart in 2017 and was focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have limited therapeutic options and affect a significant number of patients globally. The Company has three Phase 2 clini...See more

Industry & Specialities

Market Research

Countries of Operation

Australia United States of America

Headquarters:

United States of America

Company Type:

MNC / Large Enterprise

Company size:

51-200 Employees

Year Founded:

1984 (42 years)

Address:

2500 NORTHWINDS PARKWAY; STE 100; ALPHARETTA, GA 30009, US

The largest company and people database for SEA & ANZ

Employees by Department

The Rest (2)
Total (2)

Key Decision Makers

Peter Cook

MD & CEO

Bo Lin

Specialist: Molecular Biology

Insight

Signals

At a glance

Operates in multiple countries

* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.

Employees by Seniority

C-level

1employees

Senior

2employees

Non-managers

5employees

Financials

HIGH

spending power

Funding Status

Publicly listed on stock exchange

Associated Legal Entities

0 entities

Ready to get started?

Start benefiting from our free-to-use platform today

Discover More Companies

Lookalike companies

Similar industry

Featured Lists

Fast Growing SMEs
Companies with Recent Funding > 100K
Companies with High Spending Power
MNCs / Large Enterprises in Singapore

Frequently Asked Questions (FAQ)

How long has AVIRAGEN THERAPEUTICS been operating for?
What is the funding status of AVIRAGEN THERAPEUTICS?
Where is AVIRAGEN THERAPEUTICS's headquarter?
What AVIRAGEN THERAPEUTICS's spending power?
Does AVIRAGEN THERAPEUTICS have a presence in the domain it operates in?